These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 448944)

  • 1. Management of gout.
    Fox IH; Kelley WN
    JAMA; 1979 Jul; 242(4):361-4. PubMed ID: 448944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
    Simon HB
    Harv Mens Health Watch; 2010 Jan; 14(6):7-8. PubMed ID: 20464796
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug treatment of gout.
    Kelley WN; Wyngaarden JB
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract]   [Full Text] [Related]  

  • 6. Gout: joint pain and more.
    Harv Mens Health Watch; 2007 Dec; 12(5):1-3. PubMed ID: 18225332
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
    Reinders MK; Haagsma C; Jansen TL; van Roon EN; Delsing J; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jun; 68(6):892-7. PubMed ID: 18633127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Choice between uricosurics and inhibitors of uric acid synthesis in the treatment of gout].
    Kono H; Yonezawa H; Naito H
    Nihon Rinsho; 1975 Feb; 33(2):356-60. PubMed ID: 1170378
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
    [No Abstract]   [Full Text] [Related]  

  • 10. Febuxostat versus allopurinol for gout.
    Gelber AC
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract]   [Full Text] [Related]  

  • 11. [How to select and use urate lowering agents for hyperuricemia].
    Yamanaka H
    Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic gout. Case report of a severe course of disease].
    Boxberger F; Harsch IA; Brueckl WM; Hautmann M; Baum U; Hahn EG; Wein A
    Med Klin (Munich); 2003 Nov; 98(11):646-7. PubMed ID: 14631540
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is certain in gout therapy?].
    Gottesbüren H; Strohmeyer G
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract]   [Full Text] [Related]  

  • 15. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
    Zychowicz ME; Pope RS; Graser E
    J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 17. Gout: its causes, symptoms and treatment.
    Hill J
    Nurs Times; 1999 Nov 24-Dec 1; 95(47):48-50. PubMed ID: 11096905
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment failure gout: failure to treat?
    Perry ME; Madhok R
    Rheumatology (Oxford); 2010 Dec; 49(12):2233-4. PubMed ID: 20463191
    [No Abstract]   [Full Text] [Related]  

  • 19. Febuxostat efficacy in allopurinol-resistant tophaceous gout.
    Uh M; Reid G
    J Clin Rheumatol; 2011 Jun; 17(4):204-6. PubMed ID: 21617552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of urate-lowering therapies: managing the risks to gain the benefits.
    Keenan RT
    Rheum Dis Clin North Am; 2012 Nov; 38(4):663-80. PubMed ID: 23137576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.